Lymphocyte-activation gene 3 (LAG-3), a co-inhibitory receptor that highly expresses on various immune cells, binds to MHC (major histocompatibility complex) class II molecules expressed by tumor cells to negatively regulate the anti-tumor immunity [52]. Here, LAG3 is linked to neoplasm.